Chemical structure of the MLT-985 (Novartis allosteric MALT1 protease inhibitor)

allosteric MALT1 protease (paracaspase) inh.

oral QD act. in xenograft; on-target pathology

from 1M cmpd biochem. HTS and opt.

J. Med. Chem., Nov. 20, 2020

Novartis, Basel, CH

MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.